NCT07444242Recruiting
Accelerated Treatment of Depressive Patients With tDCS
Accelerated Treatment of Depressive Patients With tDCS (Twice Per Day) - a Placebo Controlled Home-based Treatment
Source: ClinicalTrials.gov · Last updated 15 Jun 2026
Brief summary (registry, in English)
A randomized, controlled three-arm study is planned to investigate the effectiveness and feasibility of an accelerated home-based tDCS application (3 weeks of transcranial direct current stimulation at home, twice daily). A total of 30 patients with depression (10 per group), who are currently not taking and have no history of taking antidepressant medication, will be randomly assigned to either an active tDCS condition, a sham (placebo) tDCS condition, or a waitlist control group. The latter two groups will receive active tDCS treatment after completion of the control phase. This study represents a continuation of the pilot study GSUND DAHOAM (Ethics approval: 20-2091-101; Dragon et al., 2024).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 24 Feb 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 30 Nov 2027
- Lead sponsor
- University of Regensburg
- Diseases
- Depression
- NCT number
- NCT07444242
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Apr 2026 to the primary completion date, 30 Nov 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participation in another clinical trial on depression within the 3 months prior to treatment initiation
Other illness
- Presence of contraindications for tDCS (e.g., electrical implants or metallic objects in the body such as a cardiac pacemaker or insulin pump, dermatological conditions affecting the scalp)
- Neurological disorders (e.g., cerebrovascular events, neurodegenerative diseases, epilepsy, brain malformations, or a history of severe head injury)
Other
- Pregnancy or breastfeeding
Who the study is looking for
- Sex: female, male, non-binary
- Age: 18-70 years
- Diagnosis of depression: no current or past psychiatric medication (current episode and history)
- Provision of informed consent to participate
- Sufficient proficiency in the German language
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Psychiatry and Psychotherapy, Center of Neuromodulation / TMS, University Regensburg Coordinator of this site? Confirm its status | Regensburg | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.